![](/img/cover-not-exists.png)
P-584 Single agent gemcitabine (GEM) in performance status (PS) 2–3patients (pts) with advanced non-small cell lung cancer (NSCLC): Effect on disease-related symptoms in a multicenter phase II trial
Tiseo, M., Tognoni, A., Carob, C., Mencoboni, M., Pennucci, M., Coialbu, T., Brema, F., Grossi, F., Pronzato, P., Ardizzoni, A.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81077-3
Date:
July, 2005
File:
PDF, 151 KB
english, 2005